Novel Inhibitory Role of Fenofibric Acid by Targeting Cryptic Site on the RBD of SARS-CoV-2
The emergence of the recent pandemic causing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has created an alarming situation worldwide. It also prompted extensive research on drug repurposing to find a potential treatment for SARS-CoV-2 infection. An active metabolite of the hyperlipi...
Main Authors: | Jianxiang Huang, Kevin C. Chan, Ruhong Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/13/2/359 |
Similar Items
-
SARS-CoV-2 RBD Conjugated to Polyglucin, Spermidine, and dsRNA Elicits a Strong Immune Response in Mice
by: Ekaterina A. Volosnikova, et al.
Published: (2023-04-01) -
SARS-CoV-2 variants impact RBD conformational dynamics and ACE2 accessibility
by: Mariana Valério, et al.
Published: (2022-10-01) -
Ultrafast Detection of SARS-CoV-2 Spike Protein (S) and Receptor-Binding Domain (RBD) in Saliva Using Surface-Enhanced Raman Spectroscopy
by: Mohammed Ba Abdullah, et al.
Published: (2022-05-01) -
Large-Scale Purification and Characterization of Recombinant Receptor-Binding Domain (RBD) of SARS-CoV-2 Spike Protein Expressed in Yeast
by: Gaurav Nagar, et al.
Published: (2023-10-01) -
Multivalent Display of SARS-CoV-2 Spike (RBD Domain) of COVID-19 to Nanomaterial, Protein Ferritin Nanocages
by: Umesh Kalathiya, et al.
Published: (2021-02-01)